STJ
Income statement / Annual
Last year (2015), St. Jude Medical, Inc.'s total revenue was $5.54 B,
a decrease of 1.44% from the previous year.
In 2015, St. Jude Medical, Inc.'s net income was $880.00 M.
See St. Jude Medical, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
FY-2011
|
FY-2010
|
FY-2009
|
FY-2008
|
FY-2007
|
FY-2006
|
| Period Ended |
01/02/2016 |
01/03/2015 |
12/28/2013 |
12/29/2012 |
12/31/2011 |
01/01/2011 |
01/02/2010 |
01/03/2009 |
12/29/2007 |
12/30/2006 |
| Operating Revenue |
$5.54 B |
$5.62 B |
$5.50 B |
$5.50 B |
$5.61 B |
$5.16 B |
$1.25 B |
$1.17 B |
$1.04 B |
$913.51 M |
| Cost of Revenue |
$1.75 B
|
$1.65 B
|
$1.57 B
|
$1.54 B
|
$1.53 B
|
$1.41 B
|
$2.47 B
|
$2.28 B
|
$2.04 B
|
$1.81 B
|
| Gross Profit |
$3.80 B
|
$3.97 B
|
$3.93 B
|
$3.97 B
|
$4.08 B
|
$3.75 B
|
-$1.22 B
|
-$1.11 B
|
-$1.00 B
|
-$898.41 M
|
| Gross Profit Ratio |
0.69
|
0.71
|
0.71
|
0.72
|
0.73
|
0.73
|
-0.97
|
-0.94
|
-0.96
|
-0.98
|
| Research and Development Expenses |
$676.00 M
|
$692.00 M
|
$691.00 M
|
$676.00 M
|
$705.06 M
|
$631.09 M
|
$559.77 M
|
$531.80 M
|
$476.33 M
|
$431.10 M
|
| General & Administrative Expenses |
$1.88 B
|
$1.86 B
|
$1.88 B
|
$1.89 B
|
$2.08 B
|
$1.82 B
|
$1.68 B
|
$1.64 B
|
$1.38 B
|
$1.20 B
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.88 B
|
$1.86 B
|
$1.88 B
|
$1.89 B
|
$2.08 B
|
$1.82 B
|
$1.68 B
|
$1.64 B
|
$1.38 B
|
$1.20 B
|
| Other Expenses |
$116.00 M
|
$89.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$2.67 B
|
$2.64 B
|
$2.58 B
|
$2.57 B
|
$2.79 B
|
$2.45 B
|
$2.24 B
|
$2.17 B
|
$1.86 B
|
$1.63 B
|
| Cost And Expenses |
$4.42 B
|
$4.29 B
|
$4.15 B
|
$4.11 B
|
$4.32 B
|
$3.86 B
|
$4.71 B
|
$4.44 B
|
$3.90 B
|
$3.44 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$103.00 M
|
$85.00 M
|
$81.00 M
|
$73.00 M
|
$69.95 M
|
$67.37 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$362.00 M
|
$310.00 M
|
$295.00 M
|
$295.00 M
|
$319.81 M
|
$244.02 M
|
$213.47 M
|
$132.31 M
|
$121.69 M
|
$94.00 M
|
| EBITDA |
$1.41 B |
$1.51 B |
$1.19 B |
$1.37 B |
$1.41 B |
$1.52 B |
$1.27 B |
$763.05 M |
$865.99 M |
$814.64 M |
| EBITDA Ratio |
0.25
|
0.27
|
0.22
|
0.25
|
0.25
|
0.29
|
1.01
|
0.65
|
0.83
|
0.89
|
| Operating Income Ratio |
0.19
|
0.2
|
0.19
|
0.2
|
0.2
|
0.25
|
0.62
|
0.54
|
0.71
|
0.79
|
| Total Other Income/Expenses Net |
-$102.00 M
|
-$83.00 M
|
-$359.00 M
|
-$95.00 M
|
-$95.17 M
|
-$68.45 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Income Before Tax |
$928.00 M
|
$1.07 B
|
$692.00 M
|
$1.01 B
|
$1.02 B
|
$1.21 B
|
$777.23 M
|
$630.74 M
|
$744.31 M
|
$720.64 M
|
| Income Before Tax Ratio |
0.17
|
0.19
|
0.13
|
0.18
|
0.18
|
0.23
|
0.62
|
0.54
|
0.71
|
0.79
|
| Income Tax Expense |
$62.00 M
|
$113.00 M
|
$92.00 M
|
$253.00 M
|
$193.28 M
|
$301.37 M
|
$0.00
|
$246.41 M
|
$185.27 M
|
$172.39 M
|
| Net Income |
$880.00 M
|
$1.00 B
|
$723.00 M
|
$752.00 M
|
$825.79 M
|
$907.44 M
|
$777.23 M
|
$384.33 M
|
$559.04 M
|
$548.25 M
|
| Net Income Ratio |
0.16
|
0.18
|
0.13
|
0.14
|
0.15
|
0.18
|
0.62
|
0.33
|
0.54
|
0.6
|
| EPS |
3.12 |
3.52 |
2.52 |
2.4 |
2.55 |
2.76 |
2.28 |
1.12 |
1.63 |
1.53 |
| EPS Diluted |
3.07 |
3.46 |
2.49 |
2.39 |
2.52 |
2.75 |
2.26 |
1.1 |
1.59 |
1.47 |
| Weighted Average Shares Out |
$282.20 M
|
$285.00 M
|
$287.00 M
|
$313.30 M
|
$324.30 M
|
$328.19 M
|
$340.88 M
|
$342.89 M
|
$342.10 M
|
$359.25 M
|
| Weighted Average Shares Out Diluted |
$286.30 M
|
$289.70 M
|
$290.60 M
|
$314.80 M
|
$327.09 M
|
$330.49 M
|
$344.36 M
|
$349.72 M
|
$352.44 M
|
$372.83 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
